WHO updates its treatment guidelines to include molnupiravir
This ninth update of WHO’s guideline on therapeutics includes a recommendation that casirivimab-imdevimab not be used for patients…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Molnupiravir
5 day course of Molnupiravir effective and safe for non-pregnant, unvaccinated COVID-19 adult…
Study conducted jointly by Fortis C-DOC, G. D Hospital & Diabetes Institute, Jawaharlal Nehru Medical College & Hospital…
Omicron patients below 60 years can start symptomatic treatment with paracetamol: Expert
We are seeing a 30 per cent hospitalisation risk reduction with the use of Molnupiravir, said Dr Dr Shashank Joshi
Potential benefits of molnupiravir outweigh risks in high risk patients: Experts
Molnupiravir is one of the two recent oral antiviral pills approved by the USFDA for COVID-19 and the first oral antiviral to…
Lupin launches Molnulup for the treatment of COVID-19 in adults in India
Clinical data suggests that it is effective on patients with co-morbidities